CHEK2 (2.5% of the patients), ATM (0.8%), and TP53 (0.8%) were the most frequently mutated genes in breast cancer, whereas ovarian cancer patients carried mutations in BRIP1 (1.7%) and MSH6 (1.3%) [34]. This evidence concerns the gene CHEK2 and ovarian carcinoma.